Back to funds
View filing
Redmile Group, LLC
hedge fundUpdated 27 days agoManaged by Redmile Group, Llc • Latest filing Q2 2026
Portfolio value
$1.5B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
-13.1%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $2.3B |
| Q2 2023 | $2.6B |
| Q3 2023 | $2.1B |
| Q4 2023 | $2.8B |
| Q1 2024 | $2.7B |
| Q2 2024 | $1.7B |
| Q3 2024 | $1.7B |
| Q4 2024 | $1.4B |
| Q1 2025 | $1.1B |
| Q2 2025 | $939.6M |
| Q3 2025 | $1B |
| Q4 2025 | $1.4B |
| Q1 2026 | $1.5B |
| Q2 2026 | $1.5B |
Top holdings
39 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | S SRRK SCHOLAR ROCK HLDG CORP | $237.1M | 4.31M | 15.92% | — |
| 2 | K KRYS KRYSTAL BIOTECH INC | $234.9M | 632.0K | 15.77% | — |
| 3 | S STOK STOKE THERAPEUTICS INC | $129.1M | 3.95M | 8.67% | — |
| 4 | I IMNM IMMUNOME INC | $104.1M | 4.91M | 6.99% | — |
| 5 | N NRIX NURIX THERAPEUTICS INC | $98.8M | 4.07M | 6.64% | — |
| 6 | A ABSI ABSCI CORPORATION | $78.1M | 6.74M | 5.24% | — |
| 7 | A ANNX ANNEXON INC | $67.8M | 11.87M | 4.55% | — |
| 8 | R RGNX REGENXBIO INC | $52.3M | 4.37M | 3.51% | — |
| 9 | S STTK SHATTUCK LABS INC | $47.8M | 6.89M | 3.21% | — |
| 10 | N NGNE NEUROGENE INC | $44.4M | 1.41M | 2.98% | — |
| 11 | B BEAM BEAM THERAPEUTICS INC | $40M | 1.16M | 2.68% | — |
| 12 | A AGMB AGOMAB THERAPEUTICS NV | $35.5M | 2.73M | 2.38% | — |
| 13 | F FATE FATE THERAPEUTICS INC | $34.8M | 12.87M | 2.33% | — |
| 14 | I IDYA IDEAYA BIOSCIENCES INC | $23.9M | 640.2K | 1.60% | — |
| 15 | S SLNCF SILENCE THERAPEUTICS PLC | $23.8M | 2.16M | 1.60% | — |
| 16 | C COGT COGENT BIOSCIENCES INC | $19.5M | 503.3K | 1.31% | — |
| 17 | S SLDB SOLID BIOSCIENCES INC | $19.5M | 1.95M | 1.31% | — |
| 18 | N NUVB NUVATION BIO INC | $17.2M | 3.03M | 1.16% | — |
| 19 | C CLDX CELLDEX THERAPEUTICS INC NEW | $16.1M | 433.9K | 1.08% | — |
| 20 | ? N/A CLIMB BIO INC | $16M | 1.23M | 1.07% | — |